Publications by authors named "Amitkumar Nitinkumar Mehta"

Claim this Profile
N
Nivolumab plus brentuximab vedotin for relapsed/refractory diffuse large B-cell lymphoma.
Nathalie A Johnson, Pier Luigi Zinzani, Eva Domingo-Domenech, Joshua Brody, Justin Kline, Amitkumar Nitinkumar Mehta

Future Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit of Rituximab Maintenance After First-line Bendamustine-Rituximab in Patients with Mantle Cell Lymphoma.
Yucai Wang, Melissa C Larson, Steven R Hwang, Diego Villa, Laveniya Kugathasan, Amitkumar Nitinkumar Mehta

Blood Adv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis